Securities code: Tinavi Medical Technologies Co.Ltd(688277) securities abbreviation: Tinavi Medical Technologies Co.Ltd(688277) Tinavi Medical Technologies Co.Ltd(688277) prospectus for issuing A-Shares to specific objects in 2021
(Registration draft)
Sponsor (lead underwriter)
May, 2002
Company statement
1. The company and all directors, supervisors and senior managers promise that there are no false records, misleading statements or major omissions in the prospectus and other information disclosure materials, and bear corresponding legal liabilities for their authenticity, accuracy and completeness.
2. The person in charge of the company, the person in charge of accounting and the person in charge of the accounting organization shall ensure that the financial and accounting materials in the prospectus are true and complete.
3. The CSRC does not guarantee the authenticity of the application, the accuracy of the investment decision or any information disclosed by the CSRC, nor does it guarantee the authenticity or accuracy of the issuer’s investment ability or the information received by the issuer. Any statement to the contrary is a false statement.
4. According to the provisions of the securities law, the issuer shall be responsible for the changes in the operation and income of the issuer after the securities are issued according to law. Investors independently judge the investment value of the issuer, make investment decisions independently, and bear the investment risks caused by changes in the operation and income of the issuer or changes in the price of securities after the issuance of securities according to law.
catalogue
interpretation…… 4 chapter I basic information of the issuer 7 I. Basic information of the issuer 7 II. Ownership structure and major shareholders 7 III. main characteristics of the industry and industry competition 11 IV. main business model, main contents of products or services 52 v. scientific and technological innovation level and mechanisms or measures to maintain scientific and technological innovation ability 65 VI. existing business development arrangements and future development strategies 69 Chapter II summary of this securities offering 70 I. background and purpose of this offering 70 II. Issuing object and relationship with the issuer 77 III. scheme summary of this issuance 78 IV. the raised funds are invested in 81 v. whether this issuance constitutes a connected transaction Vi. will this issuance lead to changes in the company’s control VII. The approval of this offering and the procedures to be submitted for approval Chapter III feasibility analysis of the board of directors on the use of the raised funds 83 I. use plan of raised funds 83 II. Basic information and feasibility analysis of the investment project with raised funds 83 III. The impact of this issuance to specific objects on the operation, management and financial status of the company 104 IV. description of the main business of the raised funds invested in the field of scientific and technological innovation 104 v. the use of the raised funds for R & D investment Chapter IV discussion and analysis of the board of directors on the impact of this issuance on the company 110 I. after the completion of this offering, the change or integration plan of the business and assets of the listed company II. Changes in the scientific research and innovation ability of listed companies after the completion of this offering III. Changes in the control structure of listed companies after the completion of this offering IV. after the completion of this offering, there is horizontal competition or potential horizontal competition between the listed company and the issuing object, the controlling shareholder and actual controller of the issuing object V. possible related party transactions between the listed company and the issuing object and the controlling shareholders and actual controllers of the issuing object after the completion of this issuance 111 Chapter V risk factors related to this offering 112 I. factors that may have a significant adverse impact on the implementation process or implementation effect of this raised investment project 112 II. Factors that may have a significant adverse impact on the company’s core competitiveness, business stability and future development 114 III. factors that may lead to the failure of this offering or insufficient funds raised 118 Chapter VI statements related to this offering 119 I. statement of the issuer and all directors, supervisors and senior managers 119 I. statement of the issuer and all directors, supervisors and senior managers 120 I. statement of the issuer and all directors, supervisors and senior managers 121 II. Statement of the controlling shareholder and actual controller of the issuer 3. The sponsor (lead underwriter) declares that 123 IV. statement of the issuer’s lawyer 125 v. statement of the accounting firm Vi. statement of the board of directors of the issuer one hundred and twenty-seven
interpretation
In this prospectus, unless the context otherwise requires, the following words have the following meanings:
Company, issuer and the company refer to Tinavi Medical Technologies Co.Ltd(688277)
Company, listed company, Tinavi Medical Technologies Co.Ltd(688277)
Anhui Tinavi Medical Technologies Co.Ltd(688277) refers to Anhui Tinavi Medical Technologies Co.Ltd(688277) Medical Technology Co., Ltd
This issuance to specific objects refers to the issuance of shares to specific objects and this issuance of shares in Tinavi Medical Technologies Co.Ltd(688277) 2021
Pricing base date refers to the base date for calculating the issue reserve price
CSRC refers to the China Securities Regulatory Commission
Shanghai Stock Exchange and stock exchange refer to Shanghai Stock Exchange
The State Council refers to the State Council of the people’s Republic of China
National Development and Reform Commission refers to the development and Reform Commission of the people’s Republic of China
Ministry of finance means the Ministry of finance of the people’s Republic of China
The State Ministry of industry and information technology and the Ministry of industry and information technology refer to the Ministry of industry and information technology of the people’s Republic of China
Company Law refers to the company law of the people’s Republic of China
Securities Law refers to the securities law of the people’s Republic of China
The articles of association refers to the Tinavi Medical Technologies Co.Ltd(688277) articles of association
General meeting of shareholders refers to Tinavi Medical Technologies Co.Ltd(688277) general meeting of shareholders
Board of directors means Tinavi Medical Technologies Co.Ltd(688277) board of directors
Board of supervisors refers to Tinavi Medical Technologies Co.Ltd(688277) board of supervisors
Also known as orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) system, it refers to the orthopaedic surgery navigation and positioning machinery and equipment that can perform specific surgery autonomously or semi autonomously according to the doctor’s planning in the process of orthopaedic surgery. It is a complete set of equipment including software and hardware.
As far as the issuer is concerned, the producer, orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) , and indicators include “GD-A”, “GD-2000 / gd-s”, “tirobot” orthopaedic hand orthopaedic Siasun Robot&Automation Co.Ltd(300024) surgery Siasun Robot&Automation Co.Ltd(300024) (also known as “Tianji”) and “tirobot forcepro superior / tirobot forcepro spine” (“Tianji 2.0”), and these products have obtained the registration certificate of class III medical devices
The reporting period refers to 2019, 2020, 2021 and January March 2022
The National Health Commission and the National Health Commission refer to the health and Health Commission of the people’s Republic of China, which was officially listed in March 2018 and assumed the responsibilities of the former national health and Family Planning Commission and other departments
The Ministry of science and technology refers to the Ministry of science and technology of the people’s Republic of China
National Health and family planning commission refers to the national health and Family Planning Commission of the people’s Republic of China
Ministry of Commerce means the Ministry of Commerce of the people’s Republic of China
Mazor robotics refers to mazor robotics Ltd., an Israeli orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) manufacturer, which was later acquired by Medtronic
Mako surgical company refers to Mako surgical Corp., a joint replacement Siasun Robot&Automation Co.Ltd(300024) manufacturer in the United States, which was later acquired by Stryker
MedTech company refers to MedTech S.A.S, a French surgery Siasun Robot&Automation Co.Ltd(300024) manufacturing enterprise, which was later acquired by Gemini bangmei
Medtronic, founded in 1949 and headquartered in the United States, is one of the largest Medtronic medical technology companies in the world. It mainly provides lifelong treatment solutions for patients with chronic diseases. It has a cardiovascular business group, a restorative therapy business group, a minimally invasive treatment business group and a diabetes business group.
Stryker Corporation, founded in 1946 and headquartered in the United States, is one of the world’s largest orthopaedic and medical technology companies, with 14 production, R & D and sales divisions around the world
Zimmer Biomet, founded in 1927 and headquartered in the United States, is committed to the design, R & D, manufacturing and marketing of orthopaedic reconstruction, spinal cord and trauma instruments, artificial dental implants and related surgical products
Smith & nephew was founded in 1856. Its business scope includes plastic and reconstructive surgery, trauma, endoscopy (including arthroscopy) and advanced wound care. It has distribution channels in more than 90 countries
BrainLAB, founded in 1989 and headquartered in Germany, is committed to developing, producing and selling software driven medical technology that supports targeted and minimally invasive treatment. Provide image guidance systems and software for surgical navigation and radiosurgery treatment planning and implementation of real-time information in the fields of neurosurgery and oncology, plastic surgery, otorhinolaryngology and so on.
Johnson & Johnson, founded in 1886, is the most comprehensive and widely distributed manufacturer of health care products and health service provider in the world. Its production and sales of products involve nursing products, medical products, medical equipment and diagnostic products
Xinjun refers to Shenzhen xinjunte intelligent medical device Co., Ltd
Double Medical Technology Inc(002901) refers to Double Medical Technology Inc(002901)
Shanghai Kinetic Medical Co.Ltd(300326) refers to Shanghai Kinetic Medical Co.Ltd(300326)
Weigao refers to Shandong Weigao group medical polymer products Co., Ltd
Aikang medical refers to Aikang medical Holding Co., Ltd
Chunli medical refers to Beijing Chunli Zhengda Medical Instrument Co., Ltd
China Securities Co.Ltd(601066) Securities – Shanghai Pudong Development Bank Co.Ltd(600000) – China Securities Co.Ltd(601066) Tinavi Medical Technologies Co.Ltd(688277) strategic placement and listing strategic placement and asset management plan refers to the asset management plan, which is the asset management plan established by the employees when the company is listed in July 2020
CE means that CE is a safety certification mark, and the European drug administration implements CE certification for medical devices
FDA means the U.S. Food and drug administration
State Food and drug administration. March 2013
